5α-Androstan-17β-ol-3-one
SIGMA/A8380 - ≥97.5%
Synonym: 17β-Hydroxy-5α-androstan-3-one; 4,5α-Dihydrotestosterone; Androstanolone; Stanolone
CAS Number: 521-18-6
Empirical Formula (Hill Notation): C19H30O2
Molecular Weight: 290.44
EC Number: 208-307-3
MDL Number: MFCD00003667
Linear Formula: C19H30O2
Product Type: Chemical
| assay | ≥97.5% |
| biological source | synthetic |
| drug control | USDEA Schedule III; Home Office Schedule 4.2; regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | powder |
| InChI | 1S/C19H30O2/c1-18-9-7-13( |
| InChI key | NVKAWKQGWWIWPM-ABEVXSGRSA |
| Quality Level | 200 ![]() |
| SMILES string | [H][C@@]12CC[C@@]3([H])[C |
| solubility | ethanol: 50 mg/mL, clear to slightly hazy, colorless to very faintly yellow |
| sterility | non-sterile |
| Application: | 5α-Androstan-17β-ol-3-one |
| Biochem/physiol Actions: | Androstanolone is an anabolic steroid. Testosterone secreted by the testis is converted to dihydrotestosterone in the target tissues where it appears to mediate many of the biological actions of testosterone. Androgens direct the development of the male phenotype during embryogenesis and at puberty. |
| Symbol | ![]() ![]() GHS07,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H302 - H351 - H360FD - H410 |
| Precautionary statements | P202 - P264 - P270 - P273 - P301 + P312 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 61-40 |
| Safety Statements | 36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97.5% |
| UNSPSC | 51111800 |




